A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Trial details
- Registry ID
- NCT06588686
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as C21
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.NCT06588686 | Vicore Pharma AB | Phase 2 | Active not recruiting | 2027-05Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |